{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T07:13:37Z","timestamp":1776755617615,"version":"3.51.2"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":2102,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1097\/jto.0b013e3181cee36e","type":"journal-article","created":{"date-parts":[[2010,2,18]],"date-time":"2010-02-18T07:11:05Z","timestamp":1266477065000},"page":"380-384","source":"Crossref","is-referenced-by-count":44,"title":["A Phase II Study of Dasatinib in Patients with Chemosensitive Relapsed Small Cell Lung Cancer (Cancer and Leukemia Group B 30602)"],"prefix":"10.1016","volume":"5","author":[{"given":"Antonius A.","family":"Miller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydia","family":"Hodgson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nithya","family":"Ramnath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory A.","family":"Otterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Kelley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Kratzke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Everett E.","family":"Vokes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/JTO.0b013e3181cee36e_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"10.1097\/JTO.0b013e3181cee36e_bib2","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.1200\/JCO.2005.04.4859","article-title":"Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database","volume":"24","author":"Govindan","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181cee36e_bib3","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1634\/theoncologist.12-9-1096","article-title":"Small cell lung cancer: have we made any progress over the last 25 years?","volume":"12","author":"Lally","year":"2007","journal-title":"Oncologist"},{"key":"10.1097\/JTO.0b013e3181cee36e_bib4","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1200\/JCO.1997.15.5.2090","volume":"15","author":"Ardizzoni","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181cee36e_bib5","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1200\/JCO.1996.14.10.2785","article-title":"Treatment of patients with small-cell lung cancer refractory to etoposide and cisplatin with the topoisomerase I poison topotecan","volume":"14","author":"Perez-Soler","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181cee36e_bib6","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1200\/JCO.1999.17.2.658","article-title":"Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer","volume":"17","author":"von Pawel","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181cee36e_bib7","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1021\/jm049486a","article-title":"Discovery of N-(2-chloro-6-methyl-phenyl)-2-(6-(4-(2-hydroxyethyl)-piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src\/Abl kinase inhibitor with potent antitumor activity in preclinical assays","volume":"47","author":"Lombardo","year":"2004","journal-title":"J Med Chem"},{"key":"10.1097\/JTO.0b013e3181cee36e_bib8","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1158\/0008-5472.CAN-05-2050","article-title":"Dasatinib (BMS-354825), a dual SRC\/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies","volume":"66","author":"Schittenhelm","year":"2006","journal-title":"Cancer Res"},{"key":"10.1097\/JTO.0b013e3181cee36e_bib9","first-page":"2416","article-title":"Preferential expression of c-Kit protooncogene transcripts in small cell lung cancer","volume":"51","author":"Sekido","year":"1991","journal-title":"Cancer Res"},{"key":"10.1097\/JTO.0b013e3181cee36e_bib10","first-page":"2291","article-title":"Coexpression of the stem cell factor and the c-Kit genes in small-cell lung cancer","volume":"6","author":"Hibi","year":"1991","journal-title":"Oncogene"},{"key":"10.1097\/JTO.0b013e3181cee36e_bib11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/bjc.1993.7","article-title":"Expression of the proto-oncogenes c-met and c-Kit and their ligands, hepatocyte growth factor\/scatter factor and stem cell factor, in SCLC cell lines and xenografts","volume":"67","author":"Rygaard","year":"1993","journal-title":"Br J Cancer"},{"key":"10.1097\/JTO.0b013e3181cee36e_bib12","first-page":"370","article-title":"Autocrine growth of small cell lung cancer mediated by coexpression of c-Kit and stem cell factor","volume":"56","author":"Krystal","year":"1996","journal-title":"Cancer Res"},{"key":"10.1097\/JTO.0b013e3181cee36e_bib13","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1164\/ajrccm\/142.6_Pt_2.S54","article-title":"src expression in small-cell lung carcinoma and other neuroendocrine malignancies","volume":"142","author":"Pahlman","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"10.1097\/JTO.0b013e3181cee36e_bib14","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1128\/MCB.7.12.4178","article-title":"Expression of c-src in cultured human neuroblastoma and small-cell lung carcinoma cell lines correlates with neurocrine differentiation","volume":"7","author":"Mellstrom","year":"1987","journal-title":"Mol Cell Biol"},{"key":"10.1097\/JTO.0b013e3181cee36e_bib15","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0959-8049(05)80056-5","article-title":"Expression of pp60c-src in human small cell and non-small cell lung carcinomas","volume":"28","author":"Mazurenko","year":"1992","journal-title":"Eur J Cancer"},{"key":"10.1097\/JTO.0b013e3181cee36e_bib16","first-page":"689","article-title":"Synergistic cell growth inhibition by the combination of amrubicin and Akt-suppressing tyrosine kinase inhibitors in small cell lung cancer cells: implication of c-Src and its inhibitor","volume":"34","author":"Ueda","year":"2009","journal-title":"Int J Oncol"},{"key":"10.1097\/JTO.0b013e3181cee36e_bib17","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1038\/sj.onc.1210819","article-title":"Essential role of Pyk2 and Src kinase activation in neuropeptide-induced proliferation of small cell lung cancer cells","volume":"27","author":"Roelle","year":"2008","journal-title":"Oncogene"},{"key":"10.1097\/JTO.0b013e3181cee36e_bib18","first-page":"4255","article-title":"Inhibition of neuropeptide-stimulated tyrosine phosphorylation and tyrosine kinase activity stimulates apoptosis in small cell lung cancer cells","volume":"56","author":"Tallet","year":"1996","journal-title":"Cancer Res"},{"key":"10.1097\/JTO.0b013e3181cee36e_bib19","doi-asserted-by":"crossref","first-page":"13754","DOI":"10.1016\/S0021-9258(18)67084-X","article-title":"Analysis of pp60c-src protein kinase activity in human tumor cell lines and tissues","volume":"261","author":"Rosen","year":"1986","journal-title":"J Biol Chem"},{"key":"10.1097\/JTO.0b013e3181cee36e_bib20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1097\/JTO.0b013e3181cee36e_bib21","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observation","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1097\/JTO.0b013e3181cee36e_bib22","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/annonc\/mdi365","article-title":"A phase II trial of imatinib (STI571) in patients with c-kit expressing relapsed small-cell lung cancer: a CALGB and NCCTG study","volume":"16","author":"Dy","year":"2005","journal-title":"Ann Oncol"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415323133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415323133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,23]],"date-time":"2021-10-23T06:22:05Z","timestamp":1634970125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086415323133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S1556086415323133"],"URL":"https:\/\/doi.org\/10.1097\/jto.0b013e3181cee36e","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}